This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

James Trager
Chief Scientific Officer at Nkarta Therapeutics, USA

Profile

James Trager is the Chief Scientific Officer of Nkarta Therapeutics. He joined Nkarta in 2016 and leads all new product discovery efforts. Dr. Trager is deeply versed in the development and application of cellular therapies for cancer. He previously served as Vice President of Research and Development at Dendreon, where he was responsible for product development, clinical immunology, analytical development, and process automation, supporting the late stage development of sipuleucel-T through clinical study, approval, and commercialization. Prior to Dendreon, Dr. Trager was a Senior Scientist at Geron, where he was part of the team that cloned human telomerase, and later established a Quality Control function to enable the manufacture and clinical development of a telomerase inhibitor.

Dr. Trager is a graduate of St. John’s College in Santa Fe New Mexico; and served as a Peace Corps volunteer in the Central African Republic. He received his doctorate in Molecular Biology and Biochemistry from the University of California at Berkeley, where he performed mechanistic studies on the src oncogene.

Agenda Sessions

  • Overcoming Cell Therapy Limitations with Next Generation Approaches based on Natural Killer Cells

    10:50am